| Announced on | Meeting on |
| Jun 05, 2024 | Jun 08, 2024 |
| Others | |
| May 23, 2024 | May 30, 2024 |
| Audited Results | |
| Mar 11, 2024 | Mar 14, 2024 |
| Others | |
| Nov 06, 2023 | Nov 13, 2023 |
| Half Yearly Results | |
| May 18, 2023 | May 30, 2023 |
| Audited Results | |
Transpact Enterprises Share Price
BSE
- OpenN.A.
- HighN.A.
- LowN.A.
- Prev CloseN.A.
- VolumeN.A.
- VWAP(₹)N.A.
Transpact Enterprise share price insights
Losing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)Transpact Enterprise Share Price Update
Transpact Enterprises Ltd. share price moved up by 5.16% from its previous close of Rs 310.00. Transpact Enterprises Ltd. stock last traded price is 326.00
Share Price Value Today/Current/Last 326.00 Previous Day 310.00
Transpact Enterprise Share Price Returns
| 1 Day | 5.16% |
| 1 Month | N.A. |
| 3 Months | N.A. |
| 1 Year | 118.13% |
| 3 Years | N.A. |
| 5 Years | N.A. |
Key Metrics
| PE Ratio(x) | 0.00 |
| EPS - TTM(₹) | 0.00 |
| MCap(₹ Cr.) | 12.61 |
| MCap Rank | 49 |
| PB Ratio(x) | N.A. |
| Div Yield(%) | N.A. |
| Face Value(₹) | 0.00 |
| 52W High(₹) | 483.80 |
| 52W Low(₹) | 120.40 |
| MCap/Sales | N.A. |
| Beta(1 Month) | N.A. |
| BV/Share(₹) | N.A. |
Transpact Enterprise Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
ADVERTISEMENT
Transpact Enterprise News & Analysis
ADVERTISEMENT
Transpact Enterprise Financials
Consolidated
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Sep 2021 Total Income 0.38 -0.38 0.38 0.00 0.00 Total Income Growth (%) -200.00 -200.00 - - - Total Expenses 0.45 -0.36 0.36 0.00 0.24 Total Expenses Growth (%) -225.37 -200.00 - -100.00 - EBIT -0.07 -0.02 0.02 0.00 -0.24 EBIT Growth (%) - -200.00 - -100.00 - Profit after Tax (PAT) -0.07 -0.02 0.02 0.00 -0.24 PAT Growth (%) - -200.00 - -100.00 - EBIT Margin (%) -17.57 6.22 6.22 - - Net Profit Margin (%) -17.23 6.22 6.22 - - Basic EPS (₹) -1.70 -0.62 0.61 0.00 -6.35 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 0.66 1.04 1.10 1.38 1.31 Total Assets Growth (%) -36.54 -5.45 -20.29 5.34 151.92 Total Liabilities 0.21 0.51 0.50 0.56 0.42 Total Liabilities Growth (%) -58.82 2.00 -10.71 33.33 55.56 Total Equity 0.44 0.53 0.60 0.82 0.88 Total Equity Growth (%) -16.98 -11.67 -26.83 -6.82 - Current Ratio (x) 2.58 0.19 0.24 0.67 0.61 Total Debt to Equity (x) 0.12 0.52 0.49 0.36 0.29 Contingent Liabilities 0.00 - - - - All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 0.62 0.01 -0.03 0.01 -1.14 Net Cash used in Investing Activities - - - - - Net Cash flow from Financing Activities -0.22 -0.02 - 0.03 1.14 Net Cash Flow 0.39 -0.01 -0.03 0.04 0.00 Closing Cash & Cash Equivalent 0.41 0.01 0.02 0.05 0.01 Closing Cash & Cash Equivalent Growth (%) 2,888.97 -32.34 -61.62 540.77 20.18 Total Debt/ CFO (x) 0.09 32.76 -9.11 26.22 -0.23 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) -20.52 -12.35 -36.85 -7.82 -49.00 Return on Capital Employed (%) -20.40 -11.98 -34.96 -6.96 -46.70 Return on Assets (%) -13.83 -6.30 -20.05 -4.64 -33.17 Interest Coverage Ratio (x) 0.00 -300.00 0.00 -577.84 -8,375.45 Asset Turnover Ratio (x) - 0.36 0.12 0.02 - Price to Earnings (x) -169.49 -55.87 -25.97 -98.04 -12.05 Price to Book (x) 34.45 6.89 9.57 7.64 5.90 EV/EBITDA (x) -257.56 -131.28 -32.96 -297.87 -14.18 EBITDA Margin (%) 0.00 -7.84 -121.53 -87.37 0.00 InsightsLosing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
ADVERTISEMENT
Peer Comparison
NAME 1D 1W 1M 3M 1Y 3Y 5Y Transpact Enterprise Stock Performance 5.16 0.00 0.00 0.00 106.72 0.00 0.00 Nureca Ltd Stock Performance -0.68 3.02 2.48 -14.26 -28.09 -81.66 0.00 Denis Chem Lab Stock Performance -2.16 3.51 -12.10 23.25 129.27 243.56 216.19 Constronics Infra Stock Performance 1.33 9.24 32.63 103.65 1165.49 1226.53 1733.33 Transgene Biotek Stock Performance 2.26 67.04 58.63 6.45 150.97 129.87 160.40 All values in %
Mutual Funds Ownership
No Data Available
ADVERTISEMENT
Corporate Actions
Board Meeting
Others
Jun 05, 2024
Board Meeting
Audited Results
May 23, 2024
Board Meeting
Others
Mar 11, 2024
No Data Available
No Data Available
No Data Available
No Data Available
Announced on Meeting on Sep 21, 2023 Sep 30, 2023 A.G.M. Sep 07, 2021 Sep 29, 2021 - Sep 07, 2020 Sep 28, 2020 Book closure from 20 Sep, 2020 to 28 Sep, 2020
ADVERTISEMENT
About
About Transpact Enterprise
Industry
Key Indices Listed On
-
Address
204, 2nd Floor,Timmy Arcade,Makwana Road Marol,Mumbai, Maharashtra - 400059
Executive Leadership
MA
Mohammed Aslam Khan
Managing DirectorAA
Anis Ahmed Choudhery
Whole Time DirectorMM
Moiz Mohsin Miyajiwala
Independent DirectorSN
Shariq Nisar
Independent DirectorShow More
Auditors
A R Sodha & Co.
M & Azam Co.
FAQs about Transpact Enterprise share
- 1. What is Transpact Enterprise share price and what are the returns for Transpact Enterprise share?As on 12 Jul, 2024, 03:31 PM IST Transpact Enterprise share price was up by 5.16% basis the previous closing price of Rs 282.2. Transpact Enterprise share price was Rs 326.00. Return Performance of Transpact Enterprise Shares:
- 1 Month: Transpact Enterprise share price moved remain unchanged by N.A.
- 3 Month: Transpact Enterprise share price moved remain unchanged by N.A.
- 6 Month: Transpact Enterprise share price moved remain unchanged by N.A.
- 2. Who owns Transpact Enterprise?Promoter owns 32.2, shares of Transpact Enterprise as on 31 Mar 2024
- Promoter holding have gone down from 32.2 (30 Sep 2023) to 18.23 (31 Mar 2024)
- Other investor holding has gone up from 67.8 (30 Sep 2023) to 81.77 (31 Mar 2024)
- 3. What are the returns for Transpact Enterprise share?Return Performance of Transpact Enterprise Shares:
- 1 Month: Transpact Enterprise share price moved remain unchanged by N.A.
- 3 Month: Transpact Enterprise share price moved remain unchanged by N.A.
- 6 Month: Transpact Enterprise share price moved remain unchanged by N.A.
- 4. What are the key metrics to analyse Transpact Enterprise Share Price?Transpact Enterprise share can be quickly analyzed on following metrics:
- Stock's PE is 0.00
- 5. What is the PE & PB ratio of Transpact Enterprise?The PE ratio of Transpact Enterprise stands at null, while the PB ratio is 27.09.
- 6. What is Transpact Enterprise's 52 week high / low?In last 52 weeks Transpact Enterprise share had a high price of Rs 483.80 and low price of Rs 120.40
- 7. What are the Transpact Enterprise quarterly results?Total Revenue and Earning for Transpact Enterprise for the year ending 2024-03-31 was Rs 0.00 Cr and Rs -0.09 Cr on Standalone basis. Last Quarter 2023-03-31, Transpact Enterprise reported an income of Rs 0.38 Cr and loss of Rs -0.07 Cr.
- 8. What is the market cap of Transpact Enterprise?Within the Hospitals & Allied Services sector, Transpact Enterprise stock has a market cap rank of 49. Transpact Enterprise has a market cap of Rs 12.61 Cr.
- 9. Who are peers to compare Transpact Enterprise share price?Top 10 Peers for Transpact Enterprise are Kretto Syscon Ltd., Span Divergent Ltd., Bandaram Pharma Packtech Ltd., Centenial Surgical Suture Ltd., GKB Ophthalmics Ltd., Shree Pacetronix Ltd., Transgene Biotek Ltd., Constronics Infra Ltd., Denis Chem Lab Ltd. and Nureca Ltd.
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.